In recent years, we have seen an increase in pharmacogenomic implementation across health care institutions and community-based pharmacy with the aim of better predicting drug response phenotypes. As multi-omics technology advances, can we predict with greater precision if an individual will have a favorable or unfavorable response to drug treatment? Join this session to learn more from a leading pharmacist pharmacogenomics expert.
